Chemocentryx (CCXI) Shareholder Baker Bros Advisors LP Trimmed Its Position by $2.07 Million; Apple (AAPL) Share Price Declined While Park Circle Co Has Raised Holding by $1.55 Million

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

Baker Bros Advisors Lp decreased its stake in Chemocentryx Inc. (CCXI) by 50% based on its latest 2018Q4 regulatory filing with the SEC. Baker Bros Advisors Lp sold 207,000 shares as the company’s stock rose 6.99% with the market. The hedge fund held 207,029 shares of the health care company at the end of 2018Q4, valued at $2.26M, down from 414,029 at the end of the previous reported quarter. Baker Bros Advisors Lp who had been investing in Chemocentryx Inc. for a number of months, seems to be less bullish one the $514.35M market cap company. The stock decreased 1.17% or $0.12 during the last trading session, reaching $10.18. About 410,542 shares traded or 37.07% up from the average. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since March 7, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 09/05/2018 – ChemoCentryx 1Q Loss/Shr 19c

Park Circle Co increased its stake in Apple Inc (AAPL) by 93.4% based on its latest 2018Q4 regulatory filing with the SEC. Park Circle Co bought 9,900 shares as the company’s stock declined 2.81% while stock markets rallied. The hedge fund held 20,500 shares of the computer manufacturing company at the end of 2018Q4, valued at $3.23 million, up from 10,600 at the end of the previous reported quarter. Park Circle Co who had been investing in Apple Inc for a number of months, seems to be bullish on the $813.56B market cap company. The stock decreased 1.14% or $1.98 during the last trading session, reaching $172.54. About 16.93 million shares traded. Apple Inc. (NASDAQ:AAPL) has risen 0.49% since March 7, 2018 and is uptrending. It has underperformed by 3.88% the S&P500. Some Historical AAPL News: 06/04/2018 – Apple CEO Tim Cook ‘deeply offended’ by ‘DACA situation’; 30/05/2018 – Engadget: Apple Music sets up publishing division as it chases down Spotify; 27/03/2018 – Qualcomm Fights Apple’s Attempt to Move Battleground to U.K; 22/05/2018 – Augmented Reality App Curate by Sotheby’s International Realty Now Available on Apple iOS; 22/03/2018 – Australian Gov: US Patent Issued to Apple on March 20 for “In application purchasing” (California Inventors); 18/05/2018 – APPLE PAYS FIRST TRANCHE OF TAX TO IRELAND: FINANCE MINISTRY; 29/03/2018 – DigiTimes: Visual Photonics VCSEL epi wafer pending Apple validation; 27/04/2018 – They believe Amazon will have a bigger impact than Apple or Google in the medical sector and are worried about hiring talent; 21/03/2018 – goCharge Introduces Wireless Charging Furniture For New Mobile Device Era; 07/03/2018 – Friends Fun Wine Captures The Taste Buds Of Americans And Takes A Bite Out Of The Big Apple With Its New Miami-lnspired Fun Wine Drink

Investors sentiment increased to 0.97 in Q4 2018. Its up 0.30, from 0.67 in 2018Q3. It is positive, as 82 investors sold AAPL shares while 860 reduced holdings. 159 funds opened positions while 756 raised stakes. 2.83 billion shares or 5.50% more from 2.68 billion shares in 2018Q3 were reported. Eulav Asset Mgmt owns 29,000 shares for 0.23% of their portfolio. Cibc Asset Mngmt invested in 0.79% or 677,626 shares. Oak Ridge Invs Ltd Company reported 250,995 shares stake. Quinn Opportunity Ptnrs Limited Company reported 0.3% in Apple Inc. (NASDAQ:AAPL). Martin & Tn invested in 1.55% or 27,844 shares. Conning Incorporated reported 130,283 shares or 0.7% of all its holdings. Charles Schwab Investment Mngmt holds 19.26M shares or 2.33% of its portfolio. Jolley Asset Mgmt Ltd Liability holds 2.62% or 21,653 shares in its portfolio. Sterneck Cap Limited Liability Company accumulated 51,452 shares or 7.9% of the stock. Fmr Limited Liability Co accumulated 112.37 million shares or 2.43% of the stock. Buckingham Asset Management Ltd Llc reported 104,198 shares. Ingalls & Snyder Limited Liability holds 2.3% of its portfolio in Apple Inc. (NASDAQ:AAPL) for 275,905 shares. Donaldson Capital Mgmt Ltd Liability Corporation owns 191,377 shares. Greatmark reported 86,019 shares. Cap Invest Advisors Limited Liability has 0.94% invested in Apple Inc. (NASDAQ:AAPL) for 89,513 shares.

Since November 19, 2018, it had 0 insider purchases, and 2 selling transactions for $902,607 activity. 1,521 shares were sold by LEVINSON ARTHUR D, worth $255,087.

More notable recent Apple Inc. (NASDAQ:AAPL) news were published by: Nasdaq.com which released: “After Hours Most Active for Mar 5, 2019 : S, FDC, M, GE, V, MSFT, ORCL, SHY, NWL, URBN, AAPL, NMRK – Nasdaq” on March 05, 2019, also Nasdaq.com with their article: “Technology Sector Update for 02/11/2019: SPI,AAPL,CAMT,RGSE – Nasdaq” published on February 11, 2019, Seekingalpha.com published: “Apple: Stress-Valuation – Seeking Alpha” on February 25, 2019. More interesting news about Apple Inc. (NASDAQ:AAPL) were released by: Nasdaq.com and their article: “Technology Sector Update for 02/08/2019: VCRA, EGAN, QNST, MSFT, AAPL, IBM, CSCO, GOOG – Nasdaq” published on February 08, 2019 as well as Seekingalpha.com‘s news article titled: “Apple’s software hiring shows Services push – Seeking Alpha” with publication date: March 04, 2019.

Park Circle Co, which manages about $122.53 million US Long portfolio, decreased its stake in Citigroup Inc by 32,000 shares to 418 shares, valued at $22,000 in 2018Q4, according to the filing.

Investors sentiment decreased to 0.93 in Q4 2018. Its down 0.05, from 0.98 in 2018Q3. It turned negative, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. Alps Advsrs reported 156,559 shares. Paw Cap has invested 0.68% in ChemoCentryx, Inc. (NASDAQ:CCXI). Strs Ohio owns 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 55,800 shares. Tiaa Cref Inv reported 0% stake. Arrowstreet Ltd Partnership accumulated 220,004 shares. Fosun Intll invested 0.06% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Matarin Capital Mngmt Ltd has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Credit Suisse Ag invested in 10,418 shares. Fernwood Mgmt Ltd Liability Co invested in 0.07% or 10,000 shares. Nantahala Cap Mgmt Lc has 0.21% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 623,338 shares. Pdts Prtnrs Ltd Llc holds 19,469 shares or 0.01% of its portfolio. Rhumbline Advisers holds 0% or 30,596 shares in its portfolio. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Invest Mgmt holds 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 37,000 shares. Gsa Capital Prtn Limited Liability Partnership stated it has 0.14% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). The New York-based Renaissance Tech has invested 0.01% in ChemoCentryx, Inc. (NASDAQ:CCXI).

Analysts await ChemoCentryx, Inc. (NASDAQ:CCXI) to report earnings on March, 8. They expect $-0.27 EPS, down 133.75% or $1.07 from last year’s $0.8 per share. After $-0.22 actual EPS reported by ChemoCentryx, Inc. for the previous quarter, Wall Street now forecasts 22.73% negative EPS growth.

Baker Bros Advisors Lp, which manages about $8.20 billion and $12.21 billion US Long portfolio, upped its stake in Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) by 11.27 million shares to 39.71 million shares, valued at $642.17M in 2018Q4, according to the filing. It also increased its holding in Krystal Biotech Inc. by 670,000 shares in the quarter, for a total of 784,674 shares, and has risen its stake in Aeglea Biotherapeutics Inc..

Apple Inc. (NASDAQ:AAPL) Institutional Positions Chart


Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *